Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of hypertonic saline inhalation around airway clearance in adults with cystic fibrosis
ACTRN12611000673943Phase 4Recruiting
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hypertonic saline in cystic fibrosis (CF) (3 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoints: Change in lung function and Subjective efficacy, tolerability, and overall satisfaction. Started Dec 2009; status: recruiting.
02
Drugs
hypertonic saline
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12611000673943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000673943.